Portal Vein Reconstruction-trans Jugular Intrahepatic Portosystemic Shunt and Portal Vein Stenting in Patients With Extrahepatic Portal Vein Obstruction

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY
Sayan Malakar , Rajanikant R. Yadav , Gaurav Pandey , Praveer Rai , Gurubasava Sajjan , Anurag Mehndiratta , Malla V.A. Gangadhar Rao , S. Rakesh Kumar , Dhruv Thakur , Pritam Das , Samir Mohindra , Supriya Sharma
{"title":"Portal Vein Reconstruction-trans Jugular Intrahepatic Portosystemic Shunt and Portal Vein Stenting in Patients With Extrahepatic Portal Vein Obstruction","authors":"Sayan Malakar ,&nbsp;Rajanikant R. Yadav ,&nbsp;Gaurav Pandey ,&nbsp;Praveer Rai ,&nbsp;Gurubasava Sajjan ,&nbsp;Anurag Mehndiratta ,&nbsp;Malla V.A. Gangadhar Rao ,&nbsp;S. Rakesh Kumar ,&nbsp;Dhruv Thakur ,&nbsp;Pritam Das ,&nbsp;Samir Mohindra ,&nbsp;Supriya Sharma","doi":"10.1016/j.jceh.2024.101437","DOIUrl":null,"url":null,"abstract":"<div><p>Extrahepatic portal vein thrombosis (EHPVO) is an uncommon cause of portal hypertension. In the long term, patients may develop portal cavernoma cholangiopathy (PCC). Up to 30%–40% of patients with EHPVO may not have shuntable veins and are often difficult to manage surgically. Interventional treatment including portal vein recanalisation-trans jugular intrahepatic portosystemic shunt (PVRecan-TIPS) has been used for patients with EHPVO. However, PV reconstruction-trans jugular intrahepatic portosystemic shunt (PVRecon-TIPS) and portal vein stenting are novel techniques for managing such patients with EHPVO with non-shuntable venous anatomy. In contrast to PVRecan-TIPS, PV reconstruction-TIPS (PVRecon-TIPS) is performed through intrahepatic collaterals. Here we present six cases of PCC who presented with recurrent acute variceal bleeding (AVB) and or refractory biliary stricture. They did not have any shuntable veins. PVRecon-TIPS was performed for five patients whilst PV stenting was done in one. Amongst the six patients, one died of sepsis whilst one who developed hyponatremia and hepatic encephalopathy was salvaged with conservative management. Following the procedure, they were started on anti-coagulation. Decompression of cavernoma was documented in all other patients. Biliary changes improved completely in 40% of patients.</p></div>","PeriodicalId":15479,"journal":{"name":"Journal of Clinical and Experimental Hepatology","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S097368832400094X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Extrahepatic portal vein thrombosis (EHPVO) is an uncommon cause of portal hypertension. In the long term, patients may develop portal cavernoma cholangiopathy (PCC). Up to 30%–40% of patients with EHPVO may not have shuntable veins and are often difficult to manage surgically. Interventional treatment including portal vein recanalisation-trans jugular intrahepatic portosystemic shunt (PVRecan-TIPS) has been used for patients with EHPVO. However, PV reconstruction-trans jugular intrahepatic portosystemic shunt (PVRecon-TIPS) and portal vein stenting are novel techniques for managing such patients with EHPVO with non-shuntable venous anatomy. In contrast to PVRecan-TIPS, PV reconstruction-TIPS (PVRecon-TIPS) is performed through intrahepatic collaterals. Here we present six cases of PCC who presented with recurrent acute variceal bleeding (AVB) and or refractory biliary stricture. They did not have any shuntable veins. PVRecon-TIPS was performed for five patients whilst PV stenting was done in one. Amongst the six patients, one died of sepsis whilst one who developed hyponatremia and hepatic encephalopathy was salvaged with conservative management. Following the procedure, they were started on anti-coagulation. Decompression of cavernoma was documented in all other patients. Biliary changes improved completely in 40% of patients.

肝外门静脉阻塞患者的门静脉重建--经颈静脉肝内门体分流术和门静脉支架植入术
肝外门静脉血栓(EHPVO)是门静脉高压症的一种不常见病因。长此以往,患者可能会发展成门静脉海绵状胆管病(PCC)。多达 30%-40% 的 EHPVO 患者可能没有可分流的静脉,通常难以通过手术治疗。介入治疗包括门静脉再通-经颈静脉肝内门体分流术(PVRecan-TIPS),已被用于治疗 EHPVO 患者。然而,PV 重建--经颈静脉肝内门体分流术(PVRecon-TIPS)和门静脉支架植入术是治疗此类静脉解剖结构不可分流的 EHPVO 患者的新技术。与PVRecan-TIPS不同,PV重建-TIPS(PVRecon-TIPS)是通过肝内袢进行的。在此,我们介绍了六例 PCC 病例,他们都出现了复发性急性静脉曲张出血(AVB)和或难治性胆道狭窄。他们没有任何可分流的静脉。五名患者接受了 PVRecon-TIPS 手术,一名患者接受了 PV 支架植入术。六名患者中,一名死于败血症,一名出现低钠血症和肝性脑病,经保守治疗后获救。手术后,他们开始接受抗凝治疗。所有其他患者的海绵体瘤均有减压记录。40%的患者胆道病变完全好转。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical and Experimental Hepatology
Journal of Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.90
自引率
16.70%
发文量
537
审稿时长
64 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信